Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuregulin-1 | 4 | 2023 | 135 | 0.980 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 5319 | 0.910 |
Why?
|
Lung Neoplasms | 10 | 2024 | 13382 | 0.820 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.800 |
Why?
|
Receptor, erbB-3 | 3 | 2023 | 143 | 0.790 |
Why?
|
Camptothecin | 2 | 2024 | 591 | 0.740 |
Why?
|
Gene Amplification | 2 | 2024 | 1087 | 0.690 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2553 | 0.680 |
Why?
|
Desmoplastic Small Round Cell Tumor | 3 | 2024 | 33 | 0.610 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.600 |
Why?
|
MAP Kinase Signaling System | 1 | 2022 | 1483 | 0.480 |
Why?
|
Soft Tissue Neoplasms | 2 | 2024 | 1158 | 0.450 |
Why?
|
Protein Kinase Inhibitors | 7 | 2024 | 5672 | 0.450 |
Why?
|
Proteomics | 3 | 2023 | 3836 | 0.390 |
Why?
|
Sarcoma | 2 | 2024 | 1800 | 0.390 |
Why?
|
Gene Expression | 1 | 2021 | 7568 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3599 | 0.280 |
Why?
|
Immunoconjugates | 2 | 2024 | 951 | 0.270 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2022 | 1608 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8542 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2024 | 368 | 0.240 |
Why?
|
Melanoma | 1 | 2022 | 5697 | 0.230 |
Why?
|
Myofibroblasts | 1 | 2024 | 223 | 0.200 |
Why?
|
S100 Proteins | 1 | 2022 | 217 | 0.200 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 16967 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4512 | 0.190 |
Why?
|
MyoD Protein | 1 | 2022 | 142 | 0.190 |
Why?
|
Solitary Fibrous Tumors | 1 | 2021 | 67 | 0.180 |
Why?
|
Receptor, trkA | 1 | 2020 | 159 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2020 | 210 | 0.160 |
Why?
|
Indazoles | 1 | 2020 | 304 | 0.160 |
Why?
|
Rhabdomyosarcoma | 1 | 2022 | 358 | 0.160 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 451 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 988 | 0.140 |
Why?
|
Telomerase | 1 | 2021 | 744 | 0.130 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 782 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 915 | 0.130 |
Why?
|
Neoplasms | 2 | 2021 | 22131 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2022 | 2425 | 0.120 |
Why?
|
Benzamides | 1 | 2020 | 1371 | 0.120 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11069 | 0.120 |
Why?
|
Language | 1 | 2024 | 1541 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1626 | 0.120 |
Why?
|
Mutation | 6 | 2023 | 30016 | 0.110 |
Why?
|
Mice | 8 | 2024 | 81368 | 0.110 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2812 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2864 | 0.100 |
Why?
|
Humans | 22 | 2024 | 760617 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2057 | 0.100 |
Why?
|
Receptor, trkC | 2 | 2020 | 63 | 0.090 |
Why?
|
WT1 Proteins | 2 | 2022 | 184 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.090 |
Why?
|
Animals | 9 | 2024 | 168201 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2022 | 5304 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2317 | 0.080 |
Why?
|
Protein Binding | 1 | 2021 | 9345 | 0.080 |
Why?
|
Prevalence | 1 | 2023 | 15689 | 0.070 |
Why?
|
Female | 7 | 2024 | 392148 | 0.070 |
Why?
|
Oncogenes | 2 | 2022 | 1221 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6340 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5367 | 0.060 |
Why?
|
Male | 6 | 2024 | 360358 | 0.060 |
Why?
|
Prognosis | 1 | 2023 | 29600 | 0.050 |
Why?
|
Solvents | 1 | 2023 | 294 | 0.050 |
Why?
|
Signal Transduction | 2 | 2023 | 23416 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2023 | 9026 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 59179 | 0.050 |
Why?
|
STAT6 Transcription Factor | 1 | 2021 | 194 | 0.050 |
Why?
|
Chromogranins | 1 | 2022 | 160 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 638 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2022 | 195 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 627 | 0.040 |
Why?
|
Molecular Conformation | 1 | 2020 | 544 | 0.040 |
Why?
|
Antibodies, Bispecific | 1 | 2022 | 196 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2024 | 1333 | 0.040 |
Why?
|
Workflow | 1 | 2024 | 849 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2024 | 1027 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2022 | 1125 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1074 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1113 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3074 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1745 | 0.030 |
Why?
|
Aged | 2 | 2024 | 169042 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2456 | 0.030 |
Why?
|
Transcription Factors | 2 | 2023 | 12116 | 0.030 |
Why?
|
Middle Aged | 2 | 2024 | 220584 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2021 | 2985 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5433 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3634 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3447 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4533 | 0.020 |
Why?
|
Child | 3 | 2024 | 80079 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9476 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12758 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13495 | 0.020 |
Why?
|
Adolescent | 2 | 2024 | 88234 | 0.010 |
Why?
|
Adult | 3 | 2024 | 220969 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9277 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18221 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27101 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80566 | 0.010 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_